Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07463430 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Suzetrigine for Non-Mastectomy Breast Surgery

StatusEnrolling by Invitation
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion moved earlier from Dec 28, 2027 to Jun 27, 2027 Completion moved earlier from Dec 31, 2027 to Jun 30, 2027 · Eligibility criteria expanded, about 13 words · Secondary endpoints: details revised at 8 of 13 entries · 2 more Show 5 more changesShow less
    • Completion moved earlier from Dec 31, 2027 to Jun 30, 2027
    • Eligibility criteria expanded, about 13 words
    • Secondary endpoints: details revised at 8 of 13 entries
    • Study description expanded, about 21 words
    • Publications: details revised at 7 of 7 entries
  2. Trial status changed: Not Yet Recruiting → Enrolling by Invitation Primary completion pushed from Aug 30, 2027 to Dec 28, 2027 · Completion pushed from Sep 30, 2027 to Dec 31, 2027 · Start date changed from estimate of Mar 30, 2026 to Apr 14, 2026 · 1 morev4 Show 4 more changesShow less
    • Primary completion pushed from Aug 30, 2027 to Dec 28, 2027
    • Completion pushed from Sep 30, 2027 to Dec 31, 2027
    • Start date changed from estimate of Mar 30, 2026 to Apr 14, 2026
    • Site contact updated
  3. Study description shortened, about 136 wordsv3 See this version in full on ClinicalTrials.gov ↗
  4. Primary completion date: Aug 15, 2027 to Aug 30, 2027 Completion date: Sep 15, 2027 to Sep 30, 2027 · Start date: Mar 15, 2026 to Mar 30, 2026 · Study description shortened, about 12 wordsv2 Show 3 more changesShow less
    • Completion date: Sep 15, 2027 to Sep 30, 2027
    • Start date: Mar 15, 2026 to Mar 30, 2026
    • Study description shortened, about 12 words

    See this version in full on ClinicalTrials.gov ↗

  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a single-center clinical study to investigate the efficacy of a Food and Drug Administration-approved analgesic, suzetrigine, to treat pain following non-mastectomy breast surgery in concert with a single-injection paravertebral nerve block.
Trial Details
NCT Number NCT07463430
Lead Sponsor University of California, San Diego
Collaborators: Vertex Pharmaceuticals Incorporated
Conditions Pain, Acute Postoperative, Breast Disease
Enrollment 120 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov